Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach.
Murphy ÁC, Weyhenmeyer B, Schmid J, Kilbride SM, Rehm M, Huber HJ, Senft C, Weissenberger J, Seifert V, Dunst M, Mittelbronn M, Kögel D, Prehn JH, Murphy BM.
Murphy ÁC, et al. Among authors: rehm m.
Cell Death Dis. 2013 May 16;4(5):e629. doi: 10.1038/cddis.2013.157.
Cell Death Dis. 2013.
PMID: 23681224
Free PMC article.